November 7, 2014

Mylan on Friday announced that it has signed an agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a severe allergic reaction. 

April 21, 2014

The 2013-2014 cough-cold season has been characterized as a moderate season with $7.5 billion in sales across total U.S. multi-outlet channels for the 52 weeks ended Jan. 26, according to IRI.

January 27, 2014

The Food and Drug Administration will hold a public meeting of the Allergenic Products Advisory Committee on Tuesday to determine the safety and efficacy of Ragwitek, a short ragweed pollen allergen extract tablet for sublingual use.

December 18, 2013

Four school districts have won a competition sponsored by Mylan to raise awareness about dangerous allergic reactions, the company said.

November 14, 2013

New legislation signed into law Wednesday encourages states to adopt laws allowing schools to maintain a supply of emergency treatments for life-threatening allergy attacks.

October 21, 2013

Nearly 1-in-50 people in the United States are at risk of severe allergic reactions, according to a new study announced Monday by the Asthma and Allergy Foundation of America.

August 20, 2013

A majority of respondents to a survey commissioned by drug maker Sanofi say that they or their children experienced a severe allergic reaction while traveling.

August 14, 2013

In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States.

June 18, 2013

A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.

May 21, 2013

A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.

February 20, 2013

A division of drug maker Mylan has distributed auto-injectors of an emergency drug used for severe allergic reactions to schools nationwide.

January 29, 2013

Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

January 24, 2013

A division of drug maker Teva is partnering with an advocacy group focused on asthma in the launch of a new educational website about the condition.

January 14, 2013

Egg allergies may no longer be a valid reason to not get a flu shot, the American College of Allergy, Asthma and Immunology announced Friday.

September 26, 2012

Mylan Specialty has hired a star of a popular TV series as a celebrity spokeswoman for a campaign designed to draw attention to severe allergic reactions.

July 24, 2012

The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

July 13, 2012

GlaxoSmithKline and Theravance submitted a regulatory application to the Food and Drug Administration for their chronic obstructive pulmonary disease treatment.

June 21, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

June 21, 2012

Drug Store News recently talked with COPD Foundation founder and president John Walsh about the organization’s new leadership. In March, the COPD Foundation took over leadership for Drive4COPD, which aims to screen people for chronic obstructive pulmonary disease, a collective term for emphysema and chronic bronchitis, which the group estimates to affect 24 million Americans who may have it but don’t know it.


May 29, 2012

A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.

May 23, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

March 29, 2012

A nonprofit organization focused on chronic obstructive pulmonary disease will take over a COPD awareness campaign from the drug company that started it.

March 29, 2012

Regulators will take a few months longer to review the approval application for a new drug for treating chronic obstructive pulmonary disease, the drug's developers said Thursday.

March 20, 2012

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.